ENHANCED SURVEILLANCE

The American Cancer Society supports screening MRI for anyone with lifetime breast cancer risk greater than 20%.

  • This would include all most anyone with a pathogenic mutation in any of the established breast cancer predisposition genes included in the modern genetic testing panels.

The NCCN guidelines have specifically endorsed enhanced surveillance with MRI for BRCA1, BRCA2, ATM, CDH1, CHEK2, NBN, NF1, PALB2, PTEN, STK11, and TP53.

 

Rodrigo Arrangoiz MS, MD, FACS

Cirugía General y Gastrointestinal
Michigan State University
Cirugía Oncológica
Fox Chase Cancer Center
Tumores de Cabeza y Cuello / Cirugía Endocrina
Fox Chase Cancer Center
Tumores de Cabeza y Cuello / Cirugía Endocrina
IFHNOS / Memorial Sloan Kettering Cancer Center
Maestría en Ciencias de Investigación
Drexel University
Certificado por el Colegio Americano de Cirugía
Fellow del Colegio Americano de Cirugía
Fellow de la Sociedad de Cirugia Oncológica
Sociedad Quirúrgica S.C.
Hospital ABC Santa Fé
Av. Carlos Graef Fernández #154

Consultorio 515
Col. Tlaxala, Delg. Cuajimalpa
México, D.F. 05300
Tel: 1103 – 1600 Ext 4515 a la 4517
Fax:1664 – 7164
 

Leave a comment